A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 85,000 shares of NRIX stock, worth $2.13 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
85,000
Previous 85,000 -0.0%
Holding current value
$2.13 Million
Previous $1.25 Billion 41.97%
% of portfolio
0.69%
Previous 0.49%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 20, 2024

BUY
$4.25 - $10.71 $361,250 - $910,350
85,000 New
85,000 $877 Million

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.18B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Portfolio

Follow Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group, based on Form 13F filings with the SEC.

News

Stay updated on Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group with notifications on news.